Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.

The cell-based product is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy that was FDA-OK'd and launched in 2023.

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that the ...

More presidential approval rating polls have been released, showing how President Donald Trump is faring in the court of public opinion. Trump had a final approval rating of 34% when he left ...

Cadillac has finally received its official approval to join the 2026 Formula 1 grid, ending a year-long drama that started when General Motors and Andretti Global's application was initially ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

The University of Oregon’s Board of Trustees unanimously approved amended contracts for Lanning, who previously earned two one-year extensions to his existing contract signed in July 2023 ...